Emergency Medicine Journal

GUIDE FOR AUTHORS

DESCRIPTION

Emergency Medicine is the premier practical, peer-reviewed monthly journal dedicated to meeting the needs of practicing emergency physicians. EM is one of the most widely read journals in our specialty, with a clear and concise style to guide emergency physicians through evaluation, diagnosis, and management. EM provides useful information that can be immediately applied to the practice of emergency medicine.

Manuscripts must be submitted via an online submission system, Editorial Manager®, at http://www.editorialmanager.com/emedjournal. If you have any questions about this system, please contact the journal office at kdesantis@frontlinemedcom.com.

GUIDE FOR AUTHORS

INTRODUCTION

Emergency Medicine publishes peer-reviewed articles and commentaries on all aspects of clinical issues in emergency medicine.

We encourage you to share your expertise with your emergency medicine colleagues by submitting articles in the following categories:

Case Reports: interesting, unique or informative cases that present and unfold in the emergency department

Reviews: thorough reviews of topics that have broad interest to the practicing emergency physician. Emphasis should be on the practical application of this information in the clinical arena.

Original Research: clinical studies with sufficient power to be implemented in clinical practice and to be of interest to practicing emergency physicians. No animal or basic science studies will be considered, and all research studies must have been conducted with Institutional Review Board approval.

Emergency Diagnostic Findings: an interesting radiographic study (including ultrasound), ECG, or an unusual physical finding with a brief synopsis.

Please note the following:

  • Papers submitted to Emergency Medicine should follow the style guidelines of the AMA Manual of Style (10th edition).
  • Papers that exceed the stipulated word counts will be returned to the author(s) for editingbefore the paper is sent out for review.
  • Papers in which the references do not follow style will also be returned to the author for revision.

TYPES OF ARTICLES

Case Reports

These reports usually describe a step-by-step approach to clinical decision making in the diagnosis and treatment of a patient who has an unusual or complicated presentation or diagnosis. They can be accompanied by a brief review of pertinent, current literature.

A case report will:

  • Be limited to 2,000 words (including references, tables, and figure titles and legends).
  • Have a title (headline) of no more than 100 characters.
  • Begin with a brief summary before the case details are presented.
  • Have no more than 2 tables and/or figures.
  • Include figures (if any) that are submitted as separate, high-resolution files.
  • Have no more than 20 references.
  • Adequately de-identify all patient information. If identifying information or figures are included, express written permission from the patient(s) must be provided at the time of manuscript submission.

Review Papers

The editors will consider invited and uninvited review papers. These manuscripts gather and summarize information from current literature and data sources on clinical topics. They should do the following:

  • Focus on novel approaches and cutting-edge therapies, as well as diagnoses, prognoses, and management.
  • Include critical assessments thereof.
  • Explore their potential for changing treatment.

Review articles are often used as guides in the practice setting, and therefore they must be systematic, must include relevant data, and must not be influenced by the authors’ opinions or biases (AMA 1.2).

The search and selection processes for research sources, such as databases, should be described in the manuscript. The research sources should be as current as possible, preferably with the search having been conducted within a few months of submission. Authors should detail in their cover letters how their review differs from existing reviews on the subject.

Review and state-of-the-art manuscripts will:

  • Be no more than 3,500 words.
  • Have a title (headline) of no more than 100 characters.
  • Have no more than 4 tables and/or figures, which should be submitted as separate files.
  • Include figures (if any) that are submitted as separate, high-resolution files.
  • Limit figures, clinical images, and tables to those necessary to highlight key data.
  • Be arranged as follows: title page; text; acknowledgments (if applicable); references; figure titles and legends; and tables.
  • Have 30 or fewer references.

Original Research Reports

These are reports on randomized trials, intervention studies, cohort studies, case-control studies, epidemiologic assessments, other observational studies, surveys, cost-effectiveness analyses, and studies of screening and diagnostic tests as they pertain to the practice of emergency medicine.

Original research reports will:

  • Be no more than 4,500 words (including a structured abstract, references, and figure titles and legends).
  • Have a structured abstract of no more than 250 words.
  • Have a title (headline) of no more than 100 characters.
  • Have no more than 5 tables and/or figures (AMA chapter 4).
  • Include figures (if any) that are submitted as separate, high-resolution files.
  • Limit figures, clinical images, and tables to those necessary to highlight key data.
  • Be arranged as follows: title page; structured abstract; abbreviations list; text; acknowledgments (if applicable); references; figure titles and legends; and tables.
  • Have 50 or fewer references, which will be in AMA style (AMA chapter 3).
  • Begin page numbering with the title page.
  • Either provide sex-specific data (when appropriate) in describing outcomes of epidemiologic analyses or clinical trials, or specifically state that no gender-based differences were present.

Research Reports

New or preliminary research findings may be considered for publication as research letters.

A research letter will:

  • Be limited to 2,000 words (including references, tables, and figure titles and legends).
  • Have an unstructured abstract of 50 or fewer words.
  • Have a title (headline) of no more than 100 characters.
  • Begin with a brief summary before the case details are presented.
  • Have no more than 2 tables and/or figures.
  • Include figures (if any) that are submitted as separate, high-resolution files.
  • Have no more than 20 references.
  • Begin page numbering with the title page.

Commentaries

Succinct opinion pieces will also be considered. These can address any current topic that has a bearing on clinical practice: research findings, health policy and/or law, ethics, or practice economics. The arguments should be focused and succinctly presented.

A commentary will:

  • Have up to 3 authors, and will provide the full name, academic degrees, and a single institutional affiliation for each author.
  • Provide disclosures for each letter author.
  • Provide the e-mail address for the corresponding letter author.
  • Be no more than 1,200 words long.
  • Have no more than 8 references (AMA chapter 3).
  • Have a title of 7 or fewer words.

Letters to the Editor

Letters to the editor should focus on a specific article that has been published in Emergency Medicine.

A letter to the editor will:

  • Have no more than 3 authors, and will provide the full name, academic degrees, and a single institutional affiliation for each author.
  • Provide disclosures, if relevant to the topic of the letter, for each letter author.
  • Provide the e-mail address for the corresponding letter author.
  • Be no more than 400 words long.
  • Have no more than 5 references.
  • Have a title of 5-7 words.

Letters will be sent for response to the authors of the original article. This response may be published or sent directly to the commentator at the discretion of the editor. Letters will be published at the discretion of the editors, and are subject to abridgement and editing for style and content. Questions or comments that could be addressed directly to authors of the original article (including complaints about missed citations) should be sent directly to those authors.

BEFORE YOU BEGIN

Ethics in Publishing

Studies should be in compliance with human studies committees of the authors' institution(s) and US Food and Drug Administration guidelines.

Studies must be performed with the participants' written informed consent. Authors must provide the details of this procedure and indicate that the institutional committee on human research has approved the study protocol. If radiation is used in a research procedure, the radiation exposure must be specified in the Methods section.

Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in your paper. Patients have a right to privacy. Therefore, identifying information – including patients' images, names, initials, or hospital numbers – should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). Written consents must be provided to the editorial office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning, and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Conflict of Interest

Emergency Medicine requires all authors to acknowledge all funding sources that supported their work, as well as all institutional or corporate affiliations of the authors. The title page must also include a publishable statement disclosing any associations (current and over the past 5 years) that might pose a conflict of interest. These include but are not limited to employment; royalties; consultant arrangements with a commercial entity; stock or other equity ownership; stock options; patent licensing arrangements; payments for conducting or publicizing a product or study; or consulting relationships with investment companies. In addition, authors are required to disclose similar associations with companies that make a competing product. When no conflicting or competing interests are present, this should be indicated in the publishable disclosure statement.

If the authors have competing or conflicting interests that cannot be disclosed in publishable statements, authors should list them in the Comments section of Editorial Manager. They should also explain these interests as well as the reason for the need for confidentiality in a statement to the Editor. The Editor asks each reviewer to disclose any competing interests or conflicts of interest that might interfere with objectivity (or to recuse him- or herself from acting as a reviewer). The Editors and members of the editorial staff will ensure that all conflicts are appropriately resolved. Conflicts that cannot be appropriately resolved will result in rejection of the manuscript or review. Undisclosed conflicts may result in sanctions, to include published statements of retraction or removal of a manuscript from the archived journal table of contents and database.

Submission Declaration

Submission of an article implies that the work described has not been previously published (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.

Authorship

Each author must have contributed significantly to the submitted work. If there are more than four authors, the contribution of each must be substantiated in the cover letter. If authorship is attributed to a group (either solely or in addition to one or more individual authors), then all members of the group must meet the full criteria and requirements for authorship. To save space, if group members have been listed in Emergency Medicine, the article should be referenced rather than reprinting the list.

The editors consider authorship to include all of the following:

  • Conception and design or analysis and interpretation of data, or both.
  • Drafting of the manuscript or revising it critically for important intellectual content.
  • Final approval of the manuscript submitted.

Participation solely in the collection of data does not justify authorship but may be appropriately acknowledged in the Acknowledgment section.

Manuscripts must be submitted with a cover letter that includes the following:

  • A statement that the paper is not under consideration elsewhere.
  • A statement that none of the paper’s content has been previously published.
  • A statement that all of the authors have read and approved the manuscript.
  • The full disclosure of any relationship with industry. (See www.icmje.org/ethical_4conflicts.html and “Role of the Funding Source,” page 7.) Exceptions must be explained.
  • Identification of a corresponding author, including all contact information. All editorial communications will be sent to this author. The corresponding author will be the person we contact for submission queries.
  • Optional: A short paragraph telling the editors why the authors think their paper merits publication priority may be included in the cover letter. Potential reviewers may be suggested in the cover letter, as well as reviewers to avoid.

Changes to Authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

  • After acceptance but before online publication. Requests to add or remove an author, or to rearrange the author names, must be sent to the Managing Editor from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged, and (b) written confirmation (e-mail, fax, letter) from all of the authors that they agree with the addition, removal, or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Managing Editor to the corresponding author, who must follow the procedure as described above. Note that publication of the accepted manuscript in an online issue is suspended until authorship has been agreed upon.
  • After acceptance and online publication. Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above, and will result in a corrigendum.

Copyright

Upon acceptance of an article, authors will be asked to complete a “Journal Publishing Agreement. Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. There are preprinted forms for use by authors in these cases.

Role of the Funding Source

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article, and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.

If the funding source(s) had no such involvement, then this should be stated.

Submission Checklist

Before you upload your manuscript to Editorial Manager for review, please check the following:

  1. Cover letter: Is a cover letter included with your manuscript submission?
  2. Title page: Is the title page presented as outlined?
  3. Corresponding author: Have you designated a corresponding author and provided current, correct contact information in the format described in AMA 2.10.4?
  4. Article authors: Have you provided first and last names and highest degrees for each author, according to the formats shown in AMA 2.2.1–2.2.4?
  5. Author affiliations: Have you included affiliations for each author according to AMA 2.3.3., as well as their current e-mail addresses?
  6. Word count: Does the word count include abstract, main running text, references, and tables, and does it appear on the title page of the manuscript?
  7. Formatting: Is your manuscript double spaced, and have you ensured that it is minimally formatted?
  8. Abstract: Have you included a structured or unstructured abstract (as stipulated by your article type) that has been formatted according to AMA 2.5 and the specific guidelines described in these guidelines?
  9. Reference citations (“callouts”) in running text/tables: Per AMA chapter 3, are the callouts in superscripts and in numerical order, and does each one match the corresponding reference in the reference list?
  10. Reference list: Are all references in the reference list complete, accurate, numerically ordered to match the callouts, and formatted according to AMA chapter 3?
  11. Tables: Have all tables been prepared according to AMA 4.1?
  12. Figures: Do all figures meet the stated quality requirements to ensure best possible print reproduction? Are their titles and legends formatted according to AMA 4.2? Have they been prepared and uploaded as separate files that are labeled with the correct naming convention?
  13. Permissions: Have you obtained permission for use of copyrighted material from other sources (including the Web), and have all appropriate forms been completed and included with the submission, according to AMA 5.6?
  14. Final read-through: Have you checked the spelling and grammar within your manuscript? Does its outline match its content?

AUTHOR INQUIRIES

For inquiries relating to the submission of articles please e-mail Kellie DeSantis at kdesantis@frontlinemedcom.com or Tracey Giannouris at tgiannouris@frontlinemedcom.com. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.